K. Polyak

Molecular Biology · 1994–2020

A researcher in the Science corpus: 20 papers; trusts 25 researchers and is trusted by 27 researchers here, as inferred from the citation graph.

Subfields

Molecular Biology — 272 citations into it; #2,116 of 17,773 by trust here, #1,570 by citations
Oncology — 238 citations into it; #40 of 1,698 by trust here, #65 by citations
Cancer Research — 181 citations into it; #182 of 1,780 by trust here, #167 by citations
Genetics — 93 citations into it; #4,621 of 6,854 by trust here, #423 by citations
Immunology — 65 citations into it
Immunology and Allergy — 15 citations into it
Biomedical Engineering — 12 citations into it
Biotechnology — 12 citations into it

Whom K. Polyak trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts K. Polyak overall

Papers from K. Polyak's perspective

Ordered by how strongly the researchers K. Polyak trusts endorse each paper. Same corpus, a different order for every researcher.

Prospective identification of tumorigenic breast cancer cells (Proceedings of the National Academy of Sciences of the United States of America)
The epithelial-mesenchymal transition generates cells with properties of stem cells. (Cell)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. (Genes & Development)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. (Cell)
Identification and expansion of human colon-cancer-initiating cells (Nature)
Molecular portraits of human breast tumours (Nature)
"Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells (Science)
Molecular requirements for epithelial-mesenchymal transition during tumor progression. (Current Opinion in Cell Biology)
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. (Cancer Research)
Migrating cancer stem cells — an integrated concept of malignant tumour progression (Nature Reviews. Cancer)

Their papers

The Genomic Landscapes of Human Breast and Colorectal Cancers (2007) — 2,499 citations
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits (2009) — 3,350 citations
Molecular definition of breast tumor heterogeneity. (2007) — 1,465 citations
Co-evolution of tumor cells and their microenvironment. (2009) — 658 citations
Intra-tumour heterogeneity: a looking glass for cancer? (2012) — 1,979 citations
Sequence analysis of mutations and translocations across breast cancer subtypes (2012) — 1,207 citations
Integrative genomic approaches identify IKBKE as a breast cancer oncogene. (2007) — 645 citations
Toward understanding and exploiting tumor heterogeneity (2015) — 708 citations
Intratumor heterogeneity: the Rosetta stone of therapy resistance (2020) — 807 citations
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution (2020) — 482 citations
Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment (2019) — 1,080 citations
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state (2011) — 1,172 citations
The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. (2011) — 890 citations
Heterogeneity in breast cancer. (2011) — 946 citations
Tumor heterogeneity: causes and consequences (2009) — 1,616 citations
The epithelial-mesenchymal transition generates cells with properties of stem cells. (2008) — 8,764 citations
Breast cancer: origins and evolution. (2007) — 671 citations
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis (2007) — 3,177 citations
Molecular characterization of the tumor microenvironment in breast cancer. (2004) — 1,266 citations
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. (1994)